紫杉醇
多重耐药
线粒体
细胞毒性
癌细胞
化学
细胞凋亡
药理学
癌症研究
抗药性
体外
癌症
生物化学
生物
医学
微生物学
内科学
抗生素
作者
Xue Fei Han,Ruijuan Su,Xiuqing Huang,Yingli Wang,Xiao Kuang,Shuang Ying Zhou,Hongzhuo Liu
标识
DOI:10.1016/j.ajps.2018.06.006
摘要
Mitochondria are currently known as novel targets for treating cancer, especially for tumors displaying multidrug resistance (MDR). This present study aimed to develop a mitochondria-targeted delivery system by using triphenylphosphonium cation (TPP+)-conjugated Brij 98 as the functional stabilizer to modify paclitaxel (PTX) nanocrystals (NCs) against drug-resistant cancer cells. Evaluations were performed on 2D monolayer and 3D multicellular spheroids (MCs) of MCF-7 cells and MCF-7/ADR cells. In comparison with free PTX and the non-targeted PTX NCs, the targeted PTX NCs showed the strongest cytotoxicity against both 2D MCF-7 and MCF-7/ADR cells, which was correlated with decreased mitochondrial membrane potential. The targeted PTX NCs exhibited deeper penetration on MCF-7 MCs and more significant growth inhibition on both MCF-7 and MCF-7/ADR MCs. The proposed strategy indicated that the TPP+-modified NCs represent a potentially viable approach for targeted chemotherapeutic molecules to mitochondria. This strategy might provide promising therapeutic outcomes to overcome MDR.
科研通智能强力驱动
Strongly Powered by AbleSci AI